To determine whether this uptake is characteristic of LSCs or both LSCs and HSCs, we isolated CD34-positive cells from bone marrow of five CML patients and categorized them immunophenotypically into CD38−/CD26+ LSCs and CD38−/CD26− HSCs. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.